Cross Country Healthcare (CCRN) Misses Q2 EPS by 3c ; Offers Guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of $0.10, $0.03 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $339.77 million versus the consensus estimate of $334.75 million.

GUIDANCE:

Cross Country Healthcare sees Q3 2024 EPS of $0.08-$0.12, versus the consensus of $0.17. Cross Country Healthcare sees Q3 2024 revenue of $305-315 million, versus the consensus of $330.9 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
• Alpha Compute reports $1.57M monthly cash flow and $1.5B pipeline